Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Daily Top 10 COVID-19 papers

DEU | ENG | ESP | FRA | ITA | POR | TUR | VNM


  Arrhythmias

  Free Subscription


Articles published in Circulation

Retrieve available abstracts of 270 articles:
HTML format



Single Articles


    May 2020
  1. LAHROUCHI N, Tadros R, Crotti L, Mizusawa Y, et al
    Transethnic Genome-Wide Association Study Provides Insights in the Genetic Architecture and Heritability of Long QT Syndrome.
    Circulation. 2020 May 20. doi: 10.1161/CIRCULATIONAHA.120.045956.
    PubMed     Abstract available


  2. TAKASUGI N, Kubota T, Okura H
    Wide QRS Complexes in an Asymptomatic Elderly Man With Permanent Atrial Fibrillation.
    Circulation. 2020;141:1656-1661.
    PubMed    


  3. POTHINENI NVK, Deo R
    Screening for Atrial Fibrillation: Closing the "LOOP".
    Circulation. 2020;141:1523-1526.
    PubMed    


  4. SMITH ED, Lakdawala NK, Papoutsidakis N, Aubert G, et al
    Desmoplakin Cardiomyopathy, a Fibrotic and Inflammatory Form of Cardiomyopathy Distinct from Typical Dilated or Arrhythmogenic Right Ventricular Cardiomyopathy.
    Circulation. 2020 May 6. doi: 10.1161/CIRCULATIONAHA.119.044934.
    PubMed     Abstract available


  5. DELMAR M, Alvarado FJ, Valdivia HH
    Desmosome-Dyad Crosstalk: An Arrhythmogenic Axis in Arrhythmogenic Right Ventricular Cardiomyopathy.
    Circulation. 2020;141:1494-1497.
    PubMed    


    April 2020
  6. GRANGER CB, Mahaffey KW
    Preventing Atrial Fibrillation With Treatments for Diabetes Mellitus.
    Circulation. 2020;141:1235-1237.
    PubMed    


    March 2020
  7. ALEXANDER JH, Wojdyla D, Vora AN, Thomas L, et al
    The Risk / Benefit Tradeoff of Antithrombotic Therapy in Patients with Atrial Fibrillation Early and Late After an Acute Coronary Syndrome or Percutaneous Coronary Intervention: Insights from AUGUSTUS.
    Circulation. 2020 Mar 29. doi: 10.1161/CIRCULATIONAHA.120.046534.
    PubMed     Abstract available


  8. LITTMANN L
    Letter by Littmann Regarding Article, "Association Between Use of Primary-Prevention Implantable Cardioverter-Defibrillators and Mortality in Patients With Heart Failure: A Prospective Propensity Score-Matched Analysis From the Swedish Heart Failure R
    Circulation. 2020;141:e646-e647.
    PubMed    


  9. SCHRAGE B, Linde C, Braunschweig F, Savarese G, et al
    Response by Schrage et al to Letter Regarding Article, "Association Between Use of Primary-Prevention Implantable Cardioverter-Defibrillators and Mortality in Patients With Heart Failure: A Prospective Propensity Score-Matched Analysis From the Swedis
    Circulation. 2020;141:e648-e649.
    PubMed    


  10. MARKMAN TM, Geng Z, Epstein AE, Nazarian S, et al
    Trends in Antiarrhythmic Drug Use Among Patients in the United States Between 2004 and 2016.
    Circulation. 2020;141:937-939.
    PubMed    


  11. STANIFER JW, Pokorney SD, Chertow GM, Hohnloser SH, et al
    Apixaban versus Warfarin in Patients with Atrial Fibrillation and Advanced Chronic Kidney Disease.
    Circulation. 2020 Mar 12. doi: 10.1161/CIRCULATIONAHA.119.044059.
    PubMed     Abstract available


  12. KAPLAN RM, Ziegler PD, Passman RS
    Response by Kaplan et al to Letter Regarding Article, "Stroke Risk as a Function of Atrial Fibrillation Duration and CHA2DS2-VASc Score".
    Circulation. 2020;141:e599-e600.
    PubMed    


  13. CAO S, Zhu X, Xia M
    Letter by Cao et al Regarding Article, "Stroke Risk as a Function of Atrial Fibrillation Duration and CHA2DS2-VASc Score".
    Circulation. 2020;141:e597-e598.
    PubMed    


  14. CHUNG MK, Eckhardt LL, Chen LY, Ahmed HM, et al
    Lifestyle and Risk Factor Modification for Reduction of Atrial Fibrillation: A Scientific Statement From the American Heart Association.
    Circulation. 2020 Mar 9:CIR0000000000000748. doi: 10.1161/CIR.0000000000000748.
    PubMed     Abstract available


  15. CAFORIO ALP, Re F, Avella A, Marcolongo R, et al
    Evidence from Family Studies for Autoimmunity in Arrhythmogenic Right Ventricular Cardiomyopathy: Associations of Circulating Anti-Heart and Anti-Intercalated Disk Autoantibodies with Disease Severity and Family History.
    Circulation. 2020 Mar 2. doi: 10.1161/CIRCULATIONAHA.119.043931.
    PubMed     Abstract available


  16. DIEDERICHSEN SZ, Haugan KJ, Kronborg C, Graff C, et al
    A Comprehensive Evaluation of Rhythm Monitoring Strategies in Screening for Atrial Fibrillation: Insights from Patients at Risk Long-Term Monitored with Implantable Loop Recorder.
    Circulation. 2020 Mar 2. doi: 10.1161/CIRCULATIONAHA.119.044407.
    PubMed     Abstract available


    February 2020
  17. SESHADRI DR, Bittel B, Browsky D, Houghtaling P, et al
    Accuracy of Apple Watch for Detection of Atrial Fibrillation.
    Circulation. 2020;141:702-703.
    PubMed    



  18. Correction to: Searching for Atrial Fibrillation Poststroke: A White Paper of the AF-SCREEN International Collaboration.
    Circulation. 2020;141:e99.
    PubMed    


  19. LUKER J, Kuhr K, Sultan A, Nolker G, et al
    Response by Luker et al to Letter Regarding Article, "Internal Versus External Electrical Cardioversion of Atrial Arrhythmia in Patients With Implantable Cardioverter-Defibrillator: A Randomized Clinical Trial".
    Circulation. 2020;141:e95-e96.
    PubMed    


  20. SUGIMOTO H, Taniguchi Y
    Letter by Sugimoto and Taniguchi Regarding Article, "Internal Versus External Electrical Cardioversion of Atrial Arrhythmia in Patients With Implantable Cardioverter-Defibrillator: A Randomized Clinical Trial".
    Circulation. 2020;141:e94.
    PubMed    


  21. INGLES J, Semsarian C
    Time to Rethink the Genetic Architecture of Long QT Syndrome.
    Circulation. 2020;141:440-443.
    PubMed    


  22. GIUDICESSI JR, Rohatgi RK, Tester DJ, Ackerman MJ, et al
    Variant Frequency and Clinical Phenotype Call Into Question the Nature of Minor, Nonsyndromic Long-QT Syndrome-Susceptibility Gene-Disease Associations.
    Circulation. 2020;141:495-497.
    PubMed    


    January 2020
  23. ADLER A, Novelli V, Amin AS, Abiusi E, et al
    An International, Multicentered, EvidenceBased Reappraisal of Genes Reported to Cause Congenital Long QT Syndrome.
    Circulation. 2020 Jan 27. doi: 10.1161/CIRCULATIONAHA.119.043132.
    PubMed    


  24. ZELNIKER TA, Bonaca MP, Furtado R, Mosenzon O, et al
    Effect of Dapagliflozin on Atrial Fibrillation in Patients with Type 2 Diabetes Mellitus: Insights from the DECLARE-TIMI 58 Trial.
    Circulation. 2020 Jan 27. doi: 10.1161/CIRCULATIONAHA.119.044183.
    PubMed     Abstract available


  25. ROBERTS JD, Asaki SY, Mazzanti A, Bos JM, et al
    An International Multi-Center Evaluation of Type 5 Long QT Syndrome: A Low Penetrant Primary Arrhythmic Condition.
    Circulation. 2020 Jan 16. doi: 10.1161/CIRCULATIONAHA.119.043114.
    PubMed     Abstract available


  26. PACKER M, Lam CSP, Lund LH, Redfield MM, et al
    Interdependence of Atrial Fibrillation and Heart Failure With a Preserved Ejection Fraction Reflects a Common Underlying Atrial and Ventricular Myopathy.
    Circulation. 2020;141:4-6.
    PubMed    


    December 2019

  27. Correction to: Extravirgin Olive Oil Consumption Reduces Risk of Atrial Fibrillation: The PREDIMED (Prevencion con Dieta Mediterranea) Trial.
    Circulation. 2019;140:e939.
    PubMed    


  28. AIMO A, Barison A, Emdin M
    Letter by Aimo et al Regarding Article, "Development and Validation of a New Risk Prediction Score for Life-Threatening Ventricular Tachyarrhythmias in Laminopathies".
    Circulation. 2019;140:e816-e817.
    PubMed    


  29. BARRIALES-VILLA R, Larranaga-Moreira JM, Ochoa JP
    Letter by Barriales-Villa et al Regarding Article, "Development and Validation of a New Risk Prediction Score for Life-Threatening Ventricular Tachyarrhythmias in Laminopathies".
    Circulation. 2019;140:e818-e819.
    PubMed    


  30. WAHBI K, Stalens C
    Response by Wahbi and Stalens to Letter Regarding Article, "Development and Validation of a New Risk Prediction Score for Life-Threatening Ventricular Tachyarrhythmias in Laminopathies".
    Circulation. 2019;140:e820-e821.
    PubMed    


    November 2019
  31. SCHNABEL RB, Haeusler KG, Healey JS, Freedman B, et al
    Searching for Atrial Fibrillation Poststroke: A White Paper of the AF-SCREEN International Collaboration.
    Circulation. 2019;140:1834-1850.
    PubMed     Abstract available


  32. NELSON AJ, Alexander JH
    Anticoagulation-Related Major Bleeding in Patients With Atrial Fibrillation: Looking Behind the Curtain.
    Circulation. 2019;140:1802-1804.
    PubMed    


  33. CALKINS H
    When It Comes to Defining the Outcomes of Catheter Ablation of Atrial Fibrillation, an Implantable Monitor Is a Great Place to Start.
    Circulation. 2019;140:1789-1791.
    PubMed    


  34. DALGAARD F, Mulder H, Wojdyla DM, Lopes RD, et al
    Patients with Atrial Fibrillation Taking Nonsteroidal Anti-Inflammatory Drugs and Oral Anticoagulants in the ARISTOTLE Trial.
    Circulation. 2019 Nov 21. doi: 10.1161/CIRCULATIONAHA.119.041296.
    PubMed     Abstract available


  35. AL-KHATIB SM, Benjamin EJ, Buxton AE, Calkins H, et al
    Research Needs and Priorities for Catheter Ablation of Atrial Fibrillation: A Report from a National Heart, Lung, and Blood Institute Virtual Workshop.
    Circulation. 2019 Nov 20. doi: 10.1161/CIRCULATIONAHA.119.042706.
    PubMed     Abstract available


  36. GHAZIZADEH Z, Kiviniemi TO, Olafsson S, Plotnick D, et al
    A Metastable Atrial State Underlies The Primary Genetic Substrate for MYL4 Mutation-Associated Atrial Fibrillation.
    Circulation. 2019 Nov 16. doi: 10.1161/CIRCULATIONAHA.119.044268.
    PubMed     Abstract available


  37. LOPES RD, Leonardi S, Wojdyla DM, Vora AN, et al
    Stent Thrombosis in Patients with Atrial Fibrillation Undergoing Coronary Stenting in the AUGUSTUS Trial.
    Circulation. 2019 Nov 11. doi: 10.1161/CIRCULATIONAHA.119.044584.
    PubMed     Abstract available


  38. NOSEWORTHY PA, Kaufman ES, Chen LY, Chung MK, et al
    Subclinical and Device-Detected Atrial Fibrillation: Pondering the Knowledge Gap: A Scientific Statement From the American Heart Association.
    Circulation. 2019 Nov 7:CIR0000000000000740. doi: 10.1161/CIR.0000000000000740.
    PubMed     Abstract available


    October 2019
  39. SIMPSON TF, Salazar JW, Tseng ZH
    Letter by Simpson et al Regarding Article, "Prophylactic Use of Implantable Cardioverter-Defibrillators in the Prevention of Sudden Cardiac Death in Dialysis Patients".
    Circulation. 2019;140:e742-e743.
    PubMed    


  40. ANDRADE JG, Champagne J, Dubuc M, Deyell MW, et al
    Cryoballoon or Radiofrequency Ablation for Atrial Fibrillation Assessed by Continuous Monitoring: A Randomized Clinical Trial.
    Circulation. 2019 Oct 21. doi: 10.1161/CIRCULATIONAHA.119.042622.
    PubMed     Abstract available


  41. SANCHEZ JM, Jolly SE, Dewland TA, Tseng ZH, et al
    Incident Atrial Fibrillation Among American Indians in California.
    Circulation. 2019 Oct 21. doi: 10.1161/CIRCULATIONAHA.119.042882.
    PubMed     Abstract available


  42. NAYYAR S, Fairley L
    Letter by Nayyar and Fairley Regarding Article, "Intracardiac Delineation of Septal Conduction in Left Bundle Branch Block Patterns: Mechanistic Evidence of Left Intrahisian Block Circumvented by His Bundle Pacing".
    Circulation. 2019;140:e711-e712.
    PubMed    


  43. PADRON-BARTHE L, Villalba-Orero M, Gomez-Salinero JM, Dominguez F, et al
    Severe Cardiac Dysfunction and Death Caused by Arrhythmogenic Right Ventricular Cardiomyopathy Type 5 Are Improved by Inhibition of Glycogen Synthase Kinase-3beta.
    Circulation. 2019;140:1188-1204.
    PubMed     Abstract available


  44. UPADHYAY GA, Cherian T, Shatz DY, Beaser AD, et al
    Response by Upadhyay et al to Letter Regarding Article, "Intracardiac Delineation of Septal Conduction in Left Bundle-Branch Block Patterns: Mechanistic Evidence of Left Intrahisian Block Circumvented by His Bundle Pacing".
    Circulation. 2019;140:e713-e714.
    PubMed    


    September 2019
  45. KAPLAN RM, Koehler J, Ziegler PD, Sarkar S, et al
    Stroke Risk as a Function of Atrial Fibrillation Duration and CHA2DS2-VASc Score.
    Circulation. 2019 Sep 30. doi: 10.1161/CIRCULATIONAHA.119.041303.
    PubMed     Abstract available


  46. WINDECKER S, Lopes RD, Massaro T, Jones-Burton C, et al
    Antithrombotic Therapy in Patients with Atrial Fibrillation and Acute Coronary Syndrome Treated Medically or with Percutaneous Coronary Intervention or Undergoing Elective Percutaneous Coronary Intervention: Insights from the AUGUSTUS Trial.
    Circulation. 2019 Sep 26. doi: 10.1161/CIRCULATIONAHA.119.043308.
    PubMed     Abstract available


  47. VORA AN, Alexander JH, Wojdyla D, Aronson R, et al
    Hospitalization among Patients with Atrial Fibrillation and a Recent Acute Coronary Syndrome or Percutaneous Coronary Intervention Treated with Apixaban or Aspirin: Insights from the AUGUSTUS Trial.
    Circulation. 2019 Sep 25. doi: 10.1161/CIRCULATIONAHA.119.043754.
    PubMed     Abstract available


  48. NADEMANEE K, Haissaguerre M, Hocini M, Nogami A, et al
    Mapping and Ablation of Ventricular Fibrillation Associated with Early Repolarization Syndrome.
    Circulation. 2019 Sep 23. doi: 10.1161/CIRCULATIONAHA.118.039022.
    PubMed     Abstract available


  49. BASSO C, Iliceto S, Thiene G, Perazzolo Marra M, et al
    Mitral Valve Prolapse, Ventricular Arrhythmias, and Sudden Death.
    Circulation. 2019;140:952-964.
    PubMed     Abstract available


  50. BENNETT AJ, Carter S, Joglar JA
    A New Tachyarrhythmia in a 60-Year-Old Woman.
    Circulation. 2019;140:965-968.
    PubMed    


  51. AL-KHATIB SM, Kusumoto FM
    Implantable Cardioverter Defibrillators Have Stood the Test of Time!
    Circulation. 2019 Sep 3. doi: 10.1161/CIRCULATIONAHA.119.043354.
    PubMed    


  52. SCHRAGE B, Uijl A, Benson L, Westermann D, et al
    Association Between Use of Primary Prevention Implantable Cardioverter-Defibrillators and Mortality in Patients with Heart Failure: A Prospective Propensity-Score Matched Analysis from the Swedish Heart Failure Registry.
    Circulation. 2019 Sep 3. doi: 10.1161/CIRCULATIONAHA.119.043012.
    PubMed     Abstract available


    August 2019
  53. LUKER J, Kuhr K, Sultan A, Nolker G, et al
    Internal vs. External Electrical Cardioversion of Atrial Arrhythmia in Patients with Implantable Cardioverter-Defibrillator: A Randomized Clinical Trial.
    Circulation. 2019 Aug 30. doi: 10.1161/CIRCULATIONAHA.119.041320.
    PubMed     Abstract available


  54. SVEDBERG N, Sundstrom J, James S, Hallmarker U, et al
    Long-Term Incidence of Atrial Fibrillation and Stroke Among Cross-Country Skiers: Cohort Study of Endurance-Trained Male and Female Athletes.
    Circulation. 2019 Aug 26. doi: 10.1161/CIRCULATIONAHA.118.039461.
    PubMed    



  55. Correction to: Impact of Physiologic Pacing Versus Right Ventricular Pacing Among Patients With Left Ventricular Ejection Fraction Greater Than 35%: A Systematic Review for the 2018 ACC/AHA/HRS Guideline on the Evaluation and Management of Patients Wi
    Circulation. 2019;140:e509.
    PubMed    



  56. Correction to: 2018 ACC/AHA/HRS Guideline on the Evaluation and Management of Patients With Bradycardia and Cardiac Conduction Delay: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical P
    Circulation. 2019;140:e504-e505.
    PubMed    



  57. Correction to: 2018 ACC/AHA/HRS Guideline on the Evaluation and Management of Patients With Bradycardia and Cardiac Conduction Delay: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
    Circulation. 2019;140:e506-e508.
    PubMed    



  58. Correction to: 2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guideli
    Circulation. 2019;140:e285.
    PubMed    


    July 2019
  59. JUMEAU R, Pruvot E, Bourhis J
    Letter by Jumeau et al Regarding Article, "Phase I/II Trial of Electrophysiology-Guided Noninvasive Cardiac Radioablation for Ventricular Tachycardia".
    Circulation. 2019;140:e1-e2.
    PubMed    


  60. ROBINSON CG, Knutson NC, Samson PP, Cuculich PS, et al
    Response by Robinson et al to Letter Regarding Article, "Phase I/II Trial of Electrophysiology-Guided Noninvasive Cardiac Radioablation for Ventricular Tachycardia".
    Circulation. 2019;140:e3-e4.
    PubMed    


    June 2019
  61. ALSINA KM, Hulsurkar M, Brandenburg S, Kownatzki-Danger D, et al
    Loss of Protein Phosphatase 1 Regulatory Subunit PPP1R3A Promotes Atrial Fibrillation.
    Circulation. 2019 Jun 12. doi: 10.1161/CIRCULATIONAHA.119.039642.
    PubMed     Abstract available


  62. GIUDICESSI JR, Noseworthy PA, Ackerman MJ
    The QT Interval.
    Circulation. 2019;139:2711-2713.
    PubMed    


  63. PRASADA S, Nishtala A, Goldschlager N
    Prolonged Ventricular Asystole.
    Circulation. 2019;139:2798-2801.
    PubMed    


  64. SAHASHI Y, Naruse G, Okura H
    Three Different Types of Tachyarrhythmia and QT Prolongation in a Suicide Attempt.
    Circulation. 2019;139:2703-2706.
    PubMed    


  65. WAHBI K, Ben Yaou R, Gandjbakhch E, Anselme F, et al
    Development and Validation of a New Risk Prediction Score for Life-Threatening Ventricular Tachyarrhythmias in Laminopathies.
    Circulation. 2019 Jun 3. doi: 10.1161/CIRCULATIONAHA.118.039410.
    PubMed     Abstract available


    May 2019
  66. LIP GYH, Khan AA, Olshansky B
    Short-Term Outcomes of Apixaban Versus Warfarin in Patients With Atrial Fibrillation.
    Circulation. 2019;139:2301-2303.
    PubMed    


  67. SEPEHRVAND N, Alemayehu W, Dyck GJB, Dyck JRB, et al
    External Validation of the H2F-PEF Model in Diagnosing Patients With Heart Failure and Preserved Ejection Fraction.
    Circulation. 2019;139:2377-2379.
    PubMed    


  68. SMITH GL, Eisner DA
    Calcium Buffering in the Heart in Health and Disease.
    Circulation. 2019;139:2358-2371.
    PubMed     Abstract available


  69. GOPINATHANNAIR R, Cornwell WK, Dukes JW, Ellis CR, et al
    Device Therapy and Arrhythmia Management in Left Ventricular Assist Device Recipients: A Scientific Statement From the American Heart Association.
    Circulation. 2019;139:e967-e989.
    PubMed     Abstract available


  70. STAM-SLOB MC, Connolly SJ, van der Graaf Y, van der Leeuw J, et al
    Individual Treatment Effect Estimation of 2 Doses of Dabigatran on Stroke and Major Bleeding in Atrial Fibrillation: Results from the RE-LY Trial.
    Circulation. 2019 May 3. doi: 10.1161/CIRCULATIONAHA.118.035266.
    PubMed     Abstract available


    April 2019

  71. Correction to: Enhanced Cardiomyocyte NLRP3 Inflammasome Signaling Promotes Atrial Fibrillation.
    Circulation. 2019;139:e889.
    PubMed    


  72. RICHTER S, Bertagnolli L, Hindricks G
    The End of a Never-Ending Story.
    Circulation. 2019;139:2069-2072.
    PubMed    


  73. KHERA R, Tang Y, Girotra S, Nadkarni VM, et al
    Pulselessness After Initiation of Cardiopulmonary Resuscitation for Bradycardia in Hospitalized Children: Prevalence, Predictors of Survival, and Implications for Hospital Profiling.
    Circulation. 2019 Apr 22. doi: 10.1161/CIRCULATIONAHA.118.039048.
    PubMed     Abstract available


  74. LARSEN TR, Padala SK, Ellenbogen KA
    Resolution of Bundle Branch Block.
    Circulation. 2019;139:1974-1976.
    PubMed    


  75. WANG TY
    Effectively Initiating and Maintaining Anticoagulation in Patients With Atrial Fibrillation.
    Circulation. 2019;139:1763-1765.
    PubMed    


  76. FADAHUNSI OO, Elsokkari I, AbdelWahab A
    Irregular Narrow Complex Tachycardia.
    Circulation. 2019;139:1848-1850.
    PubMed    


  77. WILDE AAM, Gollob MH
    Response by Wilde and Gollob to Letter Regarding Article, "Reappraisal of Reported Genes for Sudden Arrhythmic Death: Evidence-Based Evaluation of Gene Validity for Brugada Syndrome".
    Circulation. 2019;139:1760-1761.
    PubMed    


  78. LONDON B
    Letter by London Regarding Article, "Reappraisal of Reported Genes for Sudden Arrhythmic Death: Evidence-Based Evaluation of Gene Validity for Brugada Syndrome".
    Circulation. 2019;139:1758-1759.
    PubMed    


  79. ZHANG S, Doyle A, Noheria A
    Irregular Wide Complex Tachycardia-Mediated Cardiomyopathy.
    Circulation. 2019;139:1750-1752.
    PubMed    


  80. KOMATSU Y, Hocini M, Nogami A, Maury P, et al
    Catheter Ablation of Refractory Ventricular Fibrillation Storm After Myocardial Infarction: A Multicenter Study.
    Circulation. 2019 Apr 1. doi: 10.1161/CIRCULATIONAHA.118.037997.
    PubMed     Abstract available


    March 2019
  81. LEI M, Wu L, Terrar DA, Huang CL, et al
    Response by Lei et al to Letter Regarding Article, "Modernized Classification of Cardiac Antiarrhythmic Drugs".
    Circulation. 2019;139:1652-1653.
    PubMed    


  82. HU D, Huang Y, Huang C
    Letter by Hu et al Regarding Article, "Modernized Classification of Cardiac Antiarrhythmic Drugs".
    Circulation. 2019;139:1650-1651.
    PubMed    



  83. Correction to: Modernized Classification of Cardiac Antiarrhythmic Drugs.
    Circulation. 2019;139:e635.
    PubMed    


  84. COLON CM, Elrod JP, Doppalapudi H
    Limitations of Morphological Criteria.
    Circulation. 2019;139:1643-1645.
    PubMed    


  85. CHEEN MHH
    Letter by Cheen Regarding Article, "Outcomes Associated With Apixaban Use in Patients With End-Stage Kidney Disease and Atrial Fibrillation in the United States".
    Circulation. 2019;139:1561-1562.
    PubMed    


  86. SIONTIS KC, Zhang X, Schaubel DE, Yao X, et al
    Response by Siontis et al to Letter Regarding Article, "Outcomes Associated With Apixaban Use in Patients With End-Stage Kidney Disease and Atrial Fibrillation in the United States".
    Circulation. 2019;139:1563-1564.
    PubMed    


  87. YANNOPOULOS D, Bartos JA, Aufderheide TP, Callaway CW, et al
    The Evolving Role of the Cardiac Catheterization Laboratory in the Management of Patients With Out-of-Hospital Cardiac Arrest: A Scientific Statement From the American Heart Association.
    Circulation. 2019;139:e530-e552.
    PubMed     Abstract available


  88. JUKEMA JW, Timal RJ, Rotmans JI, Hensen LCR, et al
    Prophylactic Use of Implantable Cardioverter-Defibrillators in the Prevention of Sudden Cardiac Death in Dialysis Patients: The Prospective Randomized Controlled ICD2 Trial.
    Circulation. 2019 Mar 18. doi: 10.1161/CIRCULATIONAHA.119.039818.
    PubMed     Abstract available


  89. MULDER BA, van Gelder IC, Rienstra M
    Device-Detected Atrial Fibrillation: Evidencing the Knowledge Gap.
    Circulation. 2019 Mar 17. doi: 10.1161/CIRCULATIONAHA.119.040549.
    PubMed     Abstract available


  90. PERINO AC, Fan J, Askari M, Heidenreich PA, et al
    Practice Variation in Anticoagulation Prescription and Outcomes after Device-Detected Atrial Fibrillation: Insights from the Veterans Health Administration.
    Circulation. 2019 Mar 17. doi: 10.1161/CIRCULATIONAHA.118.038988.
    PubMed     Abstract available


  91. BUTT K, Ambati S
    A Peculiar Wide Complex Tachycardia.
    Circulation. 2019;139:1454-1457.
    PubMed    


  92. THIRUGANASAMBANDAMOORTHY V, Rowe BH, Sivilotti MLA, McRae AD, et al
    Duration of Electrocardiographic Monitoring of Emergency Department Patients With Syncope.
    Circulation. 2019;139:1396-1406.
    PubMed     Abstract available


    February 2019
  93. LEE SW, Lee PH, Ahn JM, Park DW, et al
    Randomized Trial Evaluating Percutaneous Coronary Intervention for the Treatment of Chronic Total Occlusion: The DECISION-CTO Trial.
    Circulation. 2019 Feb 28. doi: 10.1161/CIRCULATIONAHA.118.031313.
    PubMed     Abstract available


  94. SEDAGHAT A, Nickenig G
    Letter by Sedaghat and Nickenig Regarding Article, "Device-Related Thrombus After Left Atrial Appendage Closure: Incidence, Predictors, and Outcomes".
    Circulation. 2019;139:1241-1242.
    PubMed    


  95. QIN X, Fang E, Narisawa M, Cheng XW, et al
    Alternating P Wave Morphology.
    Circulation. 2019;139:1225-1227.
    PubMed    


  96. TOMISLAV B, Delic Brkljcaic D
    Letter by Breitenfeld and Delic Brkljacic Regarding Article, "Device-Related Thrombus After Left Atrial Appendage Closure"
    Circulation. 2019;139:1240.
    PubMed    


  97. HAUKILAHTI MAE, Holmstrom L, Vahatalo J, Kentta T, et al
    Sudden Cardiac Death in Women.
    Circulation. 2019;139:1012-1021.
    PubMed     Abstract available


  98. HOHNLOSER SH, Fudim M, Alexander JH, Wojdyla DM, et al
    Efficacy and Safety of Apixaban versus Warfarin in Patients with Atrial Fibrillation and Extremes in Body Weight: Insights from the ARISTOTLE Trial.
    Circulation. 2019 Feb 18. doi: 10.1161/CIRCULATIONAHA.118.037955.
    PubMed     Abstract available


  99. YAMADA N, Asano Y, Fujita M, Yamazaki S, et al
    Mutant KCNJ3 and KCNJ5 Potassium Channels as Novel Molecular Targets in Bradyarrhythmias and Atrial Fibrillation.
    Circulation. 2019 Feb 15. doi: 10.1161/CIRCULATIONAHA.118.036761.
    PubMed     Abstract available


  100. SCHNELL F, Carre F
    Letter by Schnell and Carre Regarding Article, "Diagnostic Yield of Genetic Testing in Young Athletes With T-Wave Inversion".
    Circulation. 2019;139:994-995.
    PubMed    


  101. SHEIKH N, Papadakis M, Wilson M, Malhotra A, et al
    Response by Sheikh et al to Letter Regarding Article, "Diagnostic Yield of Genetic Testing in Young Athletes With T-Wave Inversion".
    Circulation. 2019;139:996-997.
    PubMed    


  102. HYLEK EM
    Biomarkers for Prediction of Stroke and Bleeds in Atrial Fibrillation.
    Circulation. 2019;139:772-774.
    PubMed    


  103. LINK MS
    Important Changes for Practicing Physicians in the Focused Atrial Fibrillation Guideline Update.
    Circulation. 2019 Feb 1. doi: 10.1161/CIRCULATIONAHA.118.038300.
    PubMed    


  104. UPADHYAY GA, Cherian T, Shatz DY, Beaser AD, et al
    Intracardiac Delineation of Septal Conduction in Left Bundle Branch Block Patterns: Mechanistic Evidence of Left Intra-Hisian Block Circumvented by His Pacing.
    Circulation. 2019 Feb 1. doi: 10.1161/CIRCULATIONAHA.118.038648.
    PubMed     Abstract available


    January 2019
  105. PICCINI JP, Xu H, Cox M, Matsouaka RA, et al
    Adherence to Guideline-Directed Stroke Prevention Therapy for Atrial Fibrillation is Achievable: First Results from Get With The Guidelines-Atrial Fibrillation (GWTG-AFIB).
    Circulation. 2019 Jan 31. doi: 10.1161/CIRCULATIONAHA.118.035909.
    PubMed     Abstract available


  106. VISKIN S, Chorin E, Viskin D, Hochstadt A, et al
    Quinidine-Responsive Polymorphic Ventricular Tachycardia in Patients with Coronary Heart Disease.
    Circulation. 2019 Jan 30. doi: 10.1161/CIRCULATIONAHA.118.038036.
    PubMed     Abstract available


  107. HEEGER CH, Rillig A, Geisler D, Wohlmuth P, et al
    Left Atrial Appendage Isolation in Patients Not Responding to Pulmonary Vein Isolation.
    Circulation. 2019;139:712-715.
    PubMed    


  108. JANUARY CT, Wann LS, Calkins H, Chen LY, et al
    2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation.
    Circulation. 2019 Jan 28:CIR0000000000000665. doi: 10.1161/CIR.0000000000000665.
    PubMed    


  109. ZHANG S, Cuculich PS, Noheria A
    Atrial Flutter With Narrow QRS Complexes in a Patient With Pacemaker.
    Circulation. 2019;139:407-409.
    PubMed    


  110. ZEI PC, Mak R
    Noninvasive Stereotactic Radioablation for Ventricular Tachycardia.
    Circulation. 2019;139:322-324.
    PubMed    


  111. ROBINSON CG, Samson PP, Moore KMS, Hugo GD, et al
    Phase I/II Trial of Electrophysiology-Guided Noninvasive Cardiac Radioablation for Ventricular Tachycardia.
    Circulation. 2019;139:313-321.
    PubMed     Abstract available


  112. CHAO TF, Lip GYH, Chen SA
    Response by Chao et al to Letter Regarding Article, "Oral Anticoagulation in Very Elderly Patients With Atrial Fibrillation: A Nationwide Cohort Study".
    Circulation. 2019;139:146-147.
    PubMed    


  113. ALDAAS OM, Nishimura M, Hsu JC
    Letter by Aldaas et al Regarding Article, "Oral Anticoagulation in Very Elderly Patients With Atrial Fibrillation: A Nationwide Cohort Study".
    Circulation. 2019;139:144-145.
    PubMed    


    December 2018
  114. FRIEDMAN DJ, Al-Khatib SM
    Response by Friedman and Al-Khatib to Letter Regarding Article, "Ventricular Fibrillation Conversion Testing After Implantation of a Subcutaneous Implantable Cardioverter Defibrillator: Report From the National Cardiovascular Data Registry".
    Circulation. 2018;138:2972-2973.
    PubMed    


  115. BROUWER TF, Burke MC, Knops RE
    Letter by Brouwer et al Regarding Article, "Ventricular Fibrillation Conversion Testing After Implantation of a Subcutaneous Implantable Cardioverter Defibrillator: Report From the National Cardiovascular Data Registry".
    Circulation. 2018;138:2970-2971.
    PubMed    



  116. Correction to: Efficacy and Safety of Rivaroxaban Compared With Warfarin Among Elderly Patients With Nonvalvular Atrial Fibrillation in the Rivaroxaban Once Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of
    Circulation. 2018;138:e783.
    PubMed    


  117. AMBROSY AP, Parzynski CS, Friedman DJ, Fudim M, et al
    Is Time From Last Hospitalization for Heart Failure to Placement of a Primary Prevention Implantable Cardioverter-Defibrillator Associated With Patient Outcomes?
    Circulation. 2018;138:2787-2797.
    PubMed     Abstract available


  118. VAN REIN N, Heide-Jorgensen U, Lijfering WM, Dekkers OM, et al
    Major Bleeding Rates in Atrial Fibrillation Patients on Single, Dual, or Triple Antithrombotic Therapy: Results from a Nationwide Danish Cohort Study.
    Circulation. 2018 Dec 5. doi: 10.1161/CIRCULATIONAHA.118.036248.
    PubMed     Abstract available


  119. PANCHAL AR, Berg KM, Kudenchuk PJ, Del Rios M, et al
    2018 American Heart Association Focused Update on Advanced Cardiovascular Life Support Use of Antiarrhythmic Drugs During and Immediately After Cardiac Arrest: An Update to the American Heart Association Guidelines for Cardiopulmonary Resuscitation an
    Circulation. 2018;138:e740-e749.
    PubMed     Abstract available


  120. DUFF JP, Topjian A, Berg MD, Chan M, et al
    2018 American Heart Association Focused Update on Pediatric Advanced Life Support: An Update to the American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.
    Circulation. 2018;138:e731-e739.
    PubMed     Abstract available


  121. BARTOLOMAEUS H, Balogh A, Yakoub M, Homann S, et al
    The Short-Chain Fatty Acid Propionate Protects from Hypertensive Cardiovascular Damage.
    Circulation. 2018 Dec 4. doi: 10.1161/CIRCULATIONAHA.118.036652.
    PubMed     Abstract available


    November 2018
  122. BASSAND JP, Virdone S, Goldhaber SZ, Camm AJ, et al
    Early Risks of Death, Stroke/Systemic Embolism and Major Bleeding in Patients with Newly Diagnosed Atrial Fibrillation: Results from the GARFIELD-AF Registry.
    Circulation. 2018 Nov 28. doi: 10.1161/CIRCULATIONAHA.118.035012.
    PubMed     Abstract available


  123. VAN WAGONER DR, Chung MK
    Inflammation, Inflammasome Activation, and Atrial Fibrillation.
    Circulation. 2018;138:2243-2246.
    PubMed    


  124. BERG DD, Ruff CT, Jarolim P, Giugliano RP, et al
    Performance of the ABC Scores for Assessing the Risk of Stroke or Systemic Embolism and Bleeding in Patients with Atrial Fibrillation in ENGAGE AF-TIMI 48.
    Circulation. 2018 Nov 11. doi: 10.1161/CIRCULATIONAHA.118.038312.
    PubMed     Abstract available


  125. SLOTWINER DJ, Raitt MH, Del-Carpio Munoz F, Mulpuru SK, et al
    Impact of Physiologic Pacing Versus Right Ventricular Pacing Among Patients With Left Ventricular Ejection Fraction Greater Than 35%: A Systematic Review for the 2018 ACC/AHA/HRS Guideline on the Evaluation and Management of Patients With Bradycardia
    Circulation. 2018 Nov 6:CIR0000000000000629. doi: 10.1161/CIR.0000000000000629.
    PubMed    


  126. KUSUMOTO FM, Schoenfeld MH, Barrett C, Edgerton JR, et al
    2018 ACC/AHA/HRS Guideline on the Evaluation and Management of Patients With Bradycardia and Cardiac Conduction Delay.
    Circulation. 2018 Nov 6:CIR0000000000000628. doi: 10.1161/CIR.0000000000000628.
    PubMed    


  127. KUSUMOTO FM, Schoenfeld MH, Barrett C, Edgerton JR, et al
    2018 ACC/AHA/HRS Guideline on the Evaluation and Management of Patients With Bradycardia and Cardiac Conduction Delay: Executive Summary.
    Circulation. 2018 Nov 6:CIR0000000000000627. doi: 10.1161/CIR.0000000000000627.
    PubMed    


    October 2018
  128. DI BIASE L, Natale A, Romero J
    Thrombogenic and Arrhythmogenic Roles of the Left Atrial Appendage in Atrial Fibrillation.
    Circulation. 2018;138:2036-2050.
    PubMed     Abstract available


  129. YAGISHITA A, Goya M, Hirao K
    Simultaneous Recording of the P Wave During Atrial Fibrillation.
    Circulation. 2018;138:2057-2060.
    PubMed    


  130. LEI M, Wu L, Terrar DA, Huang CL, et al
    Modernized Classification of Cardiac Antiarrhythmic Drugs.
    Circulation. 2018;138:1879-1896.
    PubMed     Abstract available



  131. Correction to: Outcomes Associated with Apixaban Use in End-Stage Kidney Disease Patients with Atrial Fibrillation in the United States.
    Circulation. 2018;138:e425.
    PubMed    


  132. CHAO TF, Chiang CE, Lin YJ, Chang SL, et al
    Evolving Changes of the Use of Oral Anticoagulants and Outcomes in Patients With Newly Diagnosed Atrial Fibrillation in Taiwan.
    Circulation. 2018;138:1485-1487.
    PubMed    


  133. MAHESHWARI A, Norby FL, Roetker NS, Soliman EZ, et al
    Refining Prediction of Atrial Fibrillation-Related Stroke Using the P2-CHA2DS2-VASc Score: The Atherosclerosis Risk in Communities (ARIC) Study and Multi-Ethnic Study of Atherosclerosis (MESA).
    Circulation. 2018 Oct 2. doi: 10.1161/CIRCULATIONAHA.118.035411.
    PubMed     Abstract available


    September 2018

  134. Correction to: 2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Cl
    Circulation. 2018;138:e415-e418.
    PubMed    



  135. Correction to: Systematic Review for the 2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Forc
    Circulation. 2018;138:e421.
    PubMed    



  136. Correction to: 2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Gui
    Circulation. 2018;138:e419-e420.
    PubMed    


  137. LEMESLE G
    Aspirin on Top of Anticoagulation in Patients with Concomitant Stable Coronary Artery Disease and Atrial Fibrillation: No Clear Answer Yet.
    Circulation. 2018 Sep 24. doi: 10.1161/CIRCULATIONAHA.118.037440.
    PubMed    


  138. MATSUMURA-NAKANO Y, Shizuta S, Komasa A, Morimoto T, et al
    An Open-Label Randomized Trial Comparing Oral Anticoagulation with and without Single Antiplatelet Therapy in Patients with Atrial Fibrillation and Stable Coronary Artery Disease Beyond One Year after Coronary Stent Implantation: The OAC-ALONE Study.
    Circulation. 2018 Sep 24. doi: 10.1161/CIRCULATIONAHA.118.036768.
    PubMed     Abstract available


  139. DE VEER AJWM, Bennaghmouch N, Mahmoodi BK, Ten Berg JM, et al
    Response by de Veer et al to Letter Regarding Article, "Efficacy and Safety of the Use of Non-Vitamin K Antagonist Oral Anticoagulants in Patients With Nonvalvular Atrial Fibrillation and Concomitant Aspirin Therapy: A Meta-Analysis of Randomized Tria
    Circulation. 2018;138:1279.
    PubMed    


  140. TONG S, Zhang L, Joseph J
    Letter by Tong et al Regarding Article, "Efficacy and Safety of the Use of Non-Vitamin K Antagonist Oral Anticoagulants in Patients With Nonvalvular Atrial Fibrillation and Concomitant Aspirin Therapy: A Meta-Analysis of Randomized Trials".
    Circulation. 2018;138:1277-1278.
    PubMed    


  141. OKADA DR, Smith J, Derakhshan A, Gowani Z, et al
    Ventricular Arrhythmias in Cardiac Sarcoidosis.
    Circulation. 2018;138:1253-1264.
    PubMed     Abstract available


  142. HOURDAIN J, Clavel MA, Deharo JC, Asirvatham S, et al
    Common Phenotype in Patients With Mitral Valve Prolapse Who Experienced Sudden Cardiac Death.
    Circulation. 2018;138:1067-1069.
    PubMed    


    August 2018
  143. YI-TONG W
    Letter by Wang Yi-tong Regarding Article, "Ventricular Tachycardia and Electrocardiographic ST-Segment-Elevation Myocardial Infarction Without Coronary Artery Disease".
    Circulation. 2018;138:852.
    PubMed    


  144. ZAUNER CA, Holshouser JW, Littmann L
    Response to Letter Regarding Article, "Ventricular Tachycardia and Electrocardiographic ST-Segment-Elevation Myocardial Infarction Without Coronary Artery Disease".
    Circulation. 2018;138:853-854.
    PubMed    



  145. Correction to: Letter by Yang et al Regarding Article, "Use of Oral Anticoagulants for Stroke Prevention in Patients With Atrial Fibrillation Who Have a History of Intracranial Hemorrhage".
    Circulation. 2018;138:e123.
    PubMed    


  146. SARRIAS A, Bayes-Genis A
    Is Sacubitril/Valsartan (Also) an Antiarrhythmic Drug?
    Circulation. 2018;138:551-553.
    PubMed    


  147. MARTIN AC, Godier A, Narayanan K, Smadja DM, et al
    Management of Intraprocedural Anticoagulation in Patients on Non-Vitamin K Antagonist Oral Anticoagulants Undergoing Catheter Ablation for Atrial Fibrillation.
    Circulation. 2018;138:627-633.
    PubMed     Abstract available


    July 2018

  148. Correction to: Non-Vitamin K Antagonist Preferred in Patients With Nonvalvular Atrial Fibrillation and Indication for Aspirin Therapy.
    Circulation. 2018;138:e81.
    PubMed    


  149. ANGIOLILLO DJ, Goodman SG, Bhatt DL, Eikelboom JW, et al
    Antithrombotic Therapy in Patients With Atrial Fibrillation Treated With Oral Anticoagulation Undergoing Percutaneous Coronary Intervention.
    Circulation. 2018;138:527-536.
    PubMed     Abstract available


  150. BANAVALIKAR B, Shenthar J, Padmanabhan D
    Unusual Wide Complex Tachycardia During Rhythm Control for Atrial Fibrillation.
    Circulation. 2018;138:537-539.
    PubMed    


  151. OVERVAD TF, Larsen TB, Nielsen PB
    Response by Overvad et al to Letter Regarding Article, "Female Sex Is a Risk Modifier Rather Than a Risk Factor for Stroke in Atrial Fibrillation: Should We Use a CHA2DS2-VA Score Rather Than CHA2DS2-VASc?"
    Circulation. 2018;138:443-444.
    PubMed    


  152. EL-BATTRAWY I, Borggrefe M, Akin I
    Letter by El-Battrawy et al Regarding Article, "Female Sex Is a Risk Modifier Rather Than a Risk Factor for Stroke in Atrial Fibrillation: Should We Use a CHA2DS2-VASc-VA Score Rather Than CHA2DS2-VASc?"
    Circulation. 2018;138:441-442.
    PubMed    


  153. GOLD MR
    Response by Gold to Letter Regarding Article, "Treatment of Subclinical Atrial Fibrillation: Does One Plus One Always Equal Two?"
    Circulation. 2018;138:124.
    PubMed    


  154. REIFFEL JA
    Letter by Reiffel Regarding Article, "Treatment of Subclinical Atrial Fibrillation: Does One Plus One Always Equal Two?"
    Circulation. 2018;138:122-123.
    PubMed    


    June 2018
  155. SIONTIS KC, Zhang X, Eckard A, Bhave N, et al
    Outcomes Associated with Apixaban Use in End-Stage Kidney Disease Patients with Atrial Fibrillation in the United States.
    Circulation. 2018 Jun 28. pii: CIRCULATIONAHA.118.035418.
    PubMed     Abstract available


  156. SHARMA A, Hijazi Z, Andersson U, Al-Khatib SM, et al
    The Use of Biomarkers to Predict Specific Causes of Death in Patients with Atrial Fibrillation: Insights from the ARISTOTLE Trial.
    Circulation. 2018 Jun 5. pii: CIRCULATIONAHA.118.034125.
    PubMed     Abstract available



  157. Correction to: Ventricular Tachycardia Ablation in Patients With Implantable Cardioverter Defibrillators Should No Longer Be a Therapy of Last Resort.
    Circulation. 2018;137:e842.
    PubMed    


  158. ROWIN EJ, Maron MS, Maron BJ
    Response by Rowin et al to Letter Regarding Article, "Clinical Profile and Consequences of Atrial Fibrillation in Hypertrophic Cardiomyopathy".
    Circulation. 2018;137:2541-2542.
    PubMed    


  159. WANG L, Zhao YT
    Letter by Wang and Zhao Regarding Article, "Clinical Profile and Consequences of Atrial Fibrillation in Hypertrophic Cardiomyopathy".
    Circulation. 2018;137:2540.
    PubMed    


  160. ZHANG L, Xu XM
    Letter by Zhang and Xu Regarding Article, "Clinical Profile and Consequences of Atrial Fibrillation in Hypertrophic Cardiomyopathy".
    Circulation. 2018;137:2539.
    PubMed    


    May 2018
  161. PACKER M, Kowey PR
    Building Castles in the Sky: Catheter Ablation in Patients With Atrial Fibrillation and Chronic Heart Failure.
    Circulation. 2018 May 30. pii: CIRCULATIONAHA.118.034583.
    PubMed     Abstract available


  162. YAO C, Veleva T, Scott L Jr, Cao S, et al
    Enhanced Cardiomyocyte NLRP3 Inflammasome Signaling Promotes Atrial Fibrillation.
    Circulation. 2018 May 25. pii: CIRCULATIONAHA.118.035202.
    PubMed     Abstract available


  163. NAZHA B, Pandya B, Cohen J, Zhang M, et al
    Periprocedural Outcomes of Direct Oral Anticoagulants vs. Warfarin in Non-Valvular Atrial Fibrillation: A Meta-analysis of Phase III Trials.
    Circulation. 2018 May 24. pii: CIRCULATIONAHA.117.031457.
    PubMed     Abstract available


  164. REDDY YNV, Carter RE, Obokata M, Redfield MM, et al
    A Simple, Evidence-Based Approach to Help Guide Diagnosis of Heart Failure with Preserved Ejection Fraction.
    Circulation. 2018 May 23. pii: CIRCULATIONAHA.118.034646.
    PubMed     Abstract available


  165. ENRIQUEZ A, Saenz LC, Rosso R, Silvestry FE, et al
    Use of Intracardiac Echocardiography in Interventional Cardiology: Working With the Anatomy Rather Than Fighting It.
    Circulation. 2018;137:2278-2294.
    PubMed     Abstract available


  166. HALCOX JPJ, Wareham K
    Response by Halcox and Wareham to Letter Regarding Article, "Assessment of Remote Heart Rhythm Sampling Using the AliveCor Heart Monitor to Screen for Atrial Fibrillation: The REHEARSE-AF Study".
    Circulation. 2018;137:2193-2194.
    PubMed    


  167. KOSHY AN, Sajeev JK, Teh AW
    Letter by Koshy et al Regarding Article, "Assessment of Remote Heart Rhythm Sampling Using the AliveCor Heart Monitor to Screen for Atrial Fibrillation: The REHEARSE-AF Study".
    Circulation. 2018;137:2191-2192.
    PubMed    


  168. ELMING MB, Signorovitch J, Kober L, Thune JJ, et al
    Response by Elming et al to Letter Regarding Article, "Age and Outcomes of Primary Prevention Implantable Cardioverter-Defibrillators in Patients With Nonischemic Systolic Heart Failure".
    Circulation. 2018;137:2190.
    PubMed    


  169. ADABAG S, Wininger M, Singh SN
    Letter by Adabag et al Regarding Article, "Age and Outcomes of Primary Prevention Implantable Cardioverter-Defibrillators in Patients With Nonischemic Systolic Heart Failure".
    Circulation. 2018;137:2188-2189.
    PubMed    


  170. MAGNUSSEN C, Ojeda FM, Schnabel RB
    Response by Magnussen et al to Letter Regarding Article, "Sex Differences and Similarities in Atrial Fibrillation Epidemiology, Risk Factors, and Mortality in Community Cohorts: Results From the BiomarCaRE Consortium (Biomarker for Cardiovascular Risk
    Circulation. 2018;137:2087-2088.
    PubMed    


  171. WANG Y
    Letter by Wang Regarding Article, "Sex Differences and Similarities in Atrial Fibrillation Epidemiology, Risk Factors, and Mortality in Community Cohorts: Results From the BiomarCaRE Consortium (Biomarker for Cardiovascular Risk Assessment in Europe)"
    Circulation. 2018;137:2085-2086.
    PubMed    


  172. EL-BATTRAWY I, Borggrefe M, Akin I
    Letter by El-Battrawy et al Regarding Article, "Sex Differences and Similarities in Atrial Fibrillation Epidemiology, Risk Factors, and Mortality in Community Cohorts: Results From the BiomarCaRE Consortium (Biomarker for Cardiovascular Risk Assessmen
    Circulation. 2018;137:2083-2084.
    PubMed    


  173. KANAGASUNDRAM AN, John RM, Stevenson WG
    Ventricular Tachycardia Ablation in Patients With Implantable Cardioverter Defibrillators Should No Longer Be a Therapy of Last Resort.
    Circulation. 2018;137:1885-1887.
    PubMed    


    April 2018
  174. O'BRIEN EC, Holmes DN, Thomas LE, Fonarow GC, et al
    Prognostic Significance of Nuisance Bleeding in Anticoagulated Patients with Atrial Fibrillation.
    Circulation. 2018 Apr 20. pii: CIRCULATIONAHA.117.031354.
    PubMed     Abstract available


  175. CHEN LY, Chung MK, Allen LA, Ezekowitz M, et al
    Atrial Fibrillation Burden: Moving Beyond Atrial Fibrillation as a Binary Entity: A Scientific Statement From the American Heart Association.
    Circulation. 2018 Apr 16. pii: CIR.0000000000000568.
    PubMed     Abstract available


  176. TIKKANEN E, Gustafsson S, Ingelsson E
    Associations of Fitness, Physical Activity, Strength, and Genetic Risk With Cardiovascular Disease: Longitudinal Analyses in the UK Biobank Study.
    Circulation. 2018 Apr 9. pii: CIRCULATIONAHA.117.032432.
    PubMed     Abstract available


  177. LAU DH, Nattel S, Kalman JM, Sanders P, et al
    Response by Lau et al to Letters Regarding Article, "Modifiable Risk Factors and Atrial Fibrillation".
    Circulation. 2018;137:1534-1535.
    PubMed    


  178. BORGHI C, Cicero AFG
    Letter by Borghi and Cicero Regarding Article, "Modifiable Risk Factors and Atrial Fibrillation".
    Circulation. 2018;137:1532-1533.
    PubMed    


  179. ZEI PC
    Letter by Zei Regarding Article, "Modifiable Risk Factors and Atrial Fibrillation".
    Circulation. 2018;137:1530-1531.
    PubMed    


  180. SPARTALIS M, Tzatzaki E, Spartalis E
    Letter by Spartalis et al Regarding Article, "Modifiable Risk Factors and Atrial Fibrillation".
    Circulation. 2018;137:1528-1529.
    PubMed    


    March 2018
  181. ZAUNER CA, Holshouser JW, Littmann L
    Ventricular Tachycardia and Electrocardiographic ST-Segment-Elevation Myocardial Infarction Without Coronary Artery Disease.
    Circulation. 2018;137:1287-1289.
    PubMed    


  182. JAMES S
    Non-Vitamin K Antagonist Preferred in Patients With Nonvalvular Atrial Fibrillation and Indication for Aspirin Therapy.
    Circulation. 2018;137:1130-1131.
    PubMed    


  183. JAAKKOLA J, Jaakkola S, Lahdenoja O, Hurnanen T, et al
    Mobile Phone Detection of Atrial Fibrillation With Mechanocardiography: The MODE-AF Study (Mobile Phone Detection of Atrial Fibrillation).
    Circulation. 2018 Mar 11. pii: CIRCULATIONAHA.117.032804.
    PubMed     Abstract available


    February 2018
  184. CHAO TF, Liu CJ, Lin YJ, Chang SL, et al
    Oral Anticoagulation in Very Elderly Patients with Atrial Fibrillation - A Nationwide Cohort Study.
    Circulation. 2018 Feb 28. pii: CIRCULATIONAHA.117.031658.
    PubMed     Abstract available


  185. FRIEDMAN DJ, Parzynski CS, Heist EK, Russo AM, et al
    Ventricular Fibrillation Conversion Testing After Implantation of a Subcutaneous Implantable Cardioverter Defibrillator: A Report from the National Cardiovascular Data Registry.
    Circulation. 2018 Feb 20. pii: CIRCULATIONAHA.117.032167.
    PubMed     Abstract available


  186. NIELSEN PB, Skjoth F, Overvad TF, Larsen TB, et al
    Female Sex Is a Risk Modifier Rather Than a Risk Factor for Stroke in Atrial Fibrillation: Should We Use a CHA2DS2-VA Score Rather Than CHA2DS2-VASc?
    Circulation. 2018;137:832-840.
    PubMed     Abstract available


  187. BALLESTEROS G, Menendez D, Ramos P, Garcia-Bolao I, et al
    Broad... Narrow... Broad QRS Tachycardia.
    Circulation. 2018;137:743-746.
    PubMed    


  188. BEACH LY, Goldschlager N, Moss JD, Scheinman MM, et al
    Response by Beach et al to Letter Regarding Article, "Idiopathic Ventricular Fibrillation in a 29-Year-Old Man".
    Circulation. 2018;137:645.
    PubMed    


  189. JIN-SHAN H, Xue-Bin L
    Letter by Jin-shan and Xue-bin Regarding Article, "Idiopathic Ventricular Fibrillation in a 29-Year-Old Man".
    Circulation. 2018;137:643-644.
    PubMed    


  190. GIUDICESSI JR, Roden DM, Wilde AAM, Ackerman MJ, et al
    Classification and Reporting of Potentially Proarrhythmic Common Genetic Variation in Long QT Syndrome Genetic Testing.
    Circulation. 2018;137:619-630.
    PubMed     Abstract available


    January 2018
  191. REDDY YNV, Obokata M, Gersh BJ, Borlaug BA, et al
    High Prevalence of Occult Heart Failure With Preserved Ejection Fraction Among Patients With Atrial Fibrillation and Dyspnea.
    Circulation. 2018;137:534-535.
    PubMed    


  192. FARRE J, Wellens HJ
    Unique ECG During Sinus Rhythm in a Patient With a Postmyocardial Infarction-Sustained Ventricular Tachycardia.
    Circulation. 2018;137:527-530.
    PubMed    


  193. AL-KHATIB SM, Gillis AM, Curtis AB
    Centers for Medicare and Medicaid Services' Decision to Reconsider Coverage Indications for ICDs: Where to Now?
    Circulation. 2018;137:317-319.
    PubMed    


  194. GOLD MR
    Treatment of Subclinical Atrial Fibrillation: Does One Plus One Always Equal Two?
    Circulation. 2018;137:217-218.
    PubMed    


  195. YE Z, Su Q, Li L
    Letter by Ye et al Regarding Article, "Prospective Study of Adenosine on Atrioventricular Nodal Conduction in Pediatric and Young Adult Patients After Heart Transplantation".
    Circulation. 2018;137:315-316.
    PubMed    


  196. MIRANDA-ARBOLEDA AF, Correa R, Saenz G, Agudelo JF, et al
    Young Male With Incessantly Wide Complex Tachycardia: What Is the Substrate of the Arrhythmia?
    Circulation. 2018;137:300-302.
    PubMed    


  197. BARANCHUK A, Torner P, de Luna AB
    Bayes Syndrome: What Is It?
    Circulation. 2018;137:200-202.
    PubMed    


  198. FISHER M, Hill JA
    Ischemic Stroke Mandates Cross-Disciplinary Collaboration.
    Circulation. 2018;137:103-105.
    PubMed    


  199. VOIGT A, Saba S
    The Truth Is in the Details: The Case for Not Missing the Trees for the Forest.
    Circulation. 2018;137:34-37.
    PubMed    


  200. LEE JZ, Ling J, Diehl NN, Hodge DO, et al
    Mortality and Cerebrovascular Events After Heart Rhythm Disorder Management Procedures.
    Circulation. 2018;137:24-33.
    PubMed     Abstract available


    December 2017
  201. MAHIDA S, Sacher F, Dubois R, Sermesant M, et al
    Cardiac Imaging in Patients With Ventricular Tachycardia.
    Circulation. 2017;136:2491-2507.
    PubMed     Abstract available


  202. SPIRITO P
    Atrial Fibrillation in Hypertrophic Cardiomyopathy: New Light on an Old Problem.
    Circulation. 2017;136:2437-2439.
    PubMed    


  203. BUTTS B, Goeddel LA, George DJ, Steele C, et al
    Increased Inflammation in Pericardial Fluid Persists 48 Hours After Cardiac Surgery.
    Circulation. 2017;136:2284-2286.
    PubMed    


    November 2017
  204. SELMER C, Faber J
    Mild Thyroid Dysfunction: A Potential Target in Prevention of Atrial Fibrillation?
    Circulation. 2017;136:2117-2118.
    PubMed    


  205. CALKINS H, Corrado D, Marcus F
    Risk Stratification in Arrhythmogenic Right Ventricular Cardiomyopathy.
    Circulation. 2017;136:2068-2082.
    PubMed     Abstract available


  206. WENG LC, Preis SR, Hulme OL, Larson MG, et al
    Genetic Predisposition, Clinical Risk Factor Burden, and Lifetime Risk of Atrial Fibrillation.
    Circulation. 2017 Nov 12. pii: CIRCULATIONAHA.117.031431.
    PubMed     Abstract available


  207. AL-KHATIB SM, Pokorney SD
    Primary Prevention Implantable Cardioverter Defibrillators in Patients With Nonischemic Cardiomyopathy: Diminishing Returns With Advancing Age?
    Circulation. 2017;136:1781-1783.
    PubMed    


  208. SANDAU KE, Funk M, Auerbach A, Barsness GW, et al
    Update to Practice Standards for Electrocardiographic Monitoring in Hospital Settings: A Scientific Statement From the American Heart Association.
    Circulation. 2017;136:e273-e344.
    PubMed     Abstract available


  209. BENNAGHMOUCH N, de Veer AJWM, Bode K, Mahmoodi BK, et al
    The Efficacy and Safety of the Use of Non-Vitamin-K Antagonist Oral Anticoagulants in Patients with Non-Valvular Atrial Fibrillation and Concomitant Aspirin Therapy: A Meta-Analysis of Randomized Trials.
    Circulation. 2017 Nov 3. pii: CIRCULATIONAHA.117.028513.
    PubMed     Abstract available


  210. MANDALENAKIS Z, Rosengren A, Lappas G, Eriksson P, et al
    Atrial Fibrillation Burden in Young Patients with Congenital Heart Disease.
    Circulation. 2017 Nov 1. pii: CIRCULATIONAHA.117.029590.
    PubMed     Abstract available


    October 2017
  211. AL-KHATIB SM, Stevenson WG, Ackerman MJ, Bryant WJ, et al
    2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice
    Circulation. 2017 Oct 30. pii: CIR.0000000000000548.
    PubMed    


  212. KUSUMOTO FM, Bailey KR, Chaouki AS, Deshmukh AJ, et al
    Systematic Review for the 2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical P
    Circulation. 2017 Oct 30. pii: CIR.0000000000000550.
    PubMed    


  213. AL-KHATIB SM, Stevenson WG, Ackerman MJ, Bryant WJ, et al
    2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the
    Circulation. 2017 Oct 30. pii: CIR.0000000000000549.
    PubMed    


  214. BAUMGARTNER C, da Costa BR, Collet TH, Feller M, et al
    Thyroid Function Within the Normal Range, Subclinical Hypothyroidism and the Risk of Atrial Fibrillation.
    Circulation. 2017 Oct 23. pii: CIRCULATIONAHA.117.028753.
    PubMed     Abstract available


  215. BAREFIELD DY, Puckelwartz MJ, Kim EY, Wilsbacher LD, et al
    Experimental Modeling Supports a Role for MyBP-HL as a Novel Myofilament Component in Arrhythmia and Dilated Cardiomyopathy.
    Circulation. 2017;136:1477-1491.
    PubMed     Abstract available


  216. MAGNUSSEN C, Niiranen TJ, Ojeda F, Gianfagna F, et al
    Sex Differences and Similarities in Atrial Fibrillation Epidemiology, Risk Factors, and Mortality in Community Cohorts: Results From the BiomarCaRE Consortium (Biomarker for Cardiovascular Risk Assessment in Europe).
    Circulation. 2017 Oct 16. pii: CIRCULATIONAHA.117.028981.
    PubMed     Abstract available


  217. CHO JH, Zhang R, Kilfoil PJ, Gallet R, et al
    Delayed Repolarization Underlies Ventricular Arrhythmias in Rats with Heart Failure and Preserved Ejection Fraction.
    Circulation. 2017 Oct 3. pii: CIRCULATIONAHA.117.028202.
    PubMed     Abstract available


  218. WIJESURENDRA RS, Casadei B
    Seek and Ye Shall Find Subclinical Atrial Fibrillation in High-Risk Elderly Patients.
    Circulation. 2017;136:1284-1287.
    PubMed    


    September 2017
  219. BOHULA EA, Wiviott SD, Giugliano RP, Blazing MA, et al
    Prevention of Stroke with the Addition of Ezetimibe to Statin Therapy in Patients with Acute Coronary Syndrome in IMPROVE-IT.
    Circulation. 2017 Sep 30. pii: CIRCULATIONAHA.117.029095.
    PubMed     Abstract available


  220. PARKASH R, Sapp JL, Healey JS, Tang ASL, et al
    Response by Parkash et al to Letters Regarding Article, "Effect of Aggressive Blood Pressure Control on the Recurrence of Atrial Fibrillation After Catheter Ablation: A Randomized, Open-Label Clinical Trial (SMAC-AF [Substrate Modification With Aggres
    Circulation. 2017;136:1271-1272.
    PubMed    


  221. JIN-SHAN H, Xue-Bin L
    Letter by Jin-shan and Xue-bin Regarding Article, "Effect of Aggressive Blood Pressure Control on the Recurrence of Atrial Fibrillation After Catheter Ablation: A Randomized, Open-Label Clinical Trial (SMAC-AF [Substrate Modification With Aggressive B
    Circulation. 2017;136:1269-1270.
    PubMed    


  222. KOSIUK J, Linz D, Hindricks G
    Letter by Kosiuk et al Regarding Article, "Effect of Aggressive Blood Pressure Control on the Recurrence of Atrial Fibrillation After Catheter Ablation: A Randomized, Open Label Clinical Trial (SMAC-AF [Substrate Modification With Aggressive Blood Pre
    Circulation. 2017;136:1267-1268.
    PubMed    


  223. YE Z, Su Q, Li L
    Letter by Ye et al Regarding Article, "Effect of Aggressive Blood Pressure Control on the Recurrence of Atrial Fibrillation After Catheter Ablation: A Randomized, Open Label Clinical Trial (SMAC-AF [Substrate Modification with Aggressive Blood Pressur
    Circulation. 2017;136:1265-1266.
    PubMed    


  224. KAPUR S, Barbhaiya C, Deneke T, Michaud GF, et al
    Esophageal Injury and Atrioesophageal Fistula Caused by Ablation for Atrial Fibrillation.
    Circulation. 2017;136:1247-1255.
    PubMed     Abstract available


  225. ROWIN EJ, Hausvater A, Link MS, Abt P, et al
    Clinical Profile and Consequences of Atrial Fibrillation in Hypertrophic Cardiomyopathy.
    Circulation. 2017 Sep 15. pii: CIRCULATIONAHA.117.029267.
    PubMed     Abstract available


  226. KUDENCHUK PJ, Leroux BG, Daya M, Rea T, et al
    Antiarrhythmic Drugs for Non-Shockable-Turned-Shockable Out-of-Hospital Cardiac Arrest: The Amiodarone, Lidocaine or Placebo Study (ALPS).
    Circulation. 2017 Sep 13. pii: CIRCULATIONAHA.117.028624.
    PubMed     Abstract available


  227. AUFFRET V, Puri R, Urena M, Chamandi C, et al
    Conduction Disturbances After Transcatheter Aortic Valve Replacement: Current Status and Future Perspectives.
    Circulation. 2017;136:1049-1069.
    PubMed     Abstract available


  228. ELMING MB, Nielsen JC, Haarbo J, Videbaek L, et al
    Age and Outcomes of Primary Prevention Implantable Cardioverter Defibrillators in Patients with Non-Ischemic Systolic Heart Failure.
    Circulation. 2017 Sep 6. pii: CIRCULATIONAHA.117.028829.
    PubMed     Abstract available


    August 2017
  229. WALDO AL, Camm AJ
    Atrial Fibrillation: Atrial High-Rate Events (AHRES): Look and You Will Find-Then What?
    Circulation. 2017 Aug 28. pii: CIRCULATIONAHA.117.030705.
    PubMed     Abstract available


  230. HALCOX JPJ, Wareham K, Cardew A, Gilmore M, et al
    Assessment of Remote Heart Rhythm Sampling Using the AliveCor Heart Monitor to Screen for Atrial Fibrillation: The REHEARSE-AF Study.
    Circulation. 2017 Aug 28. pii: CIRCULATIONAHA.117.030583.
    PubMed     Abstract available


  231. LAU DH, Nattel S, Kalman JM, Sanders P, et al
    Modifiable Risk Factors and Atrial Fibrillation.
    Circulation. 2017;136:583-596.
    PubMed     Abstract available


  232. HEALEY JS, Alings M, Ha AC, Leong-Sit P, et al
    Subclinical Atrial Fibrillation in Older Patients.
    Circulation. 2017 Aug 4. pii: CIRCULATIONAHA.117.028845.
    PubMed     Abstract available


  233. KALMAN JM, Sanders P, Rosso R, Calkins H, et al
    Should We Perform Catheter Ablation for Asymptomatic Atrial Fibrillation?
    Circulation. 2017;136:490-499.
    PubMed     Abstract available


    July 2017
  234. CHATTERJEE NA, Chasman DI, Albert CM
    Response by Chatterjee et al to Letter Regarding Article, "Genetic Obesity and the Risk of Atrial Fibrillation: Causal Estimates From Mendelian Randomization".
    Circulation. 2017;136:434-435.
    PubMed    


  235. KON KOH K
    Letter by Koh Regarding Article, "Genetic Obesity and the Risk of Atrial Fibrillation: Causal Estimates from Mendelian Randomization".
    Circulation. 2017;136:432-433.
    PubMed    


  236. GIBSON CM, Fox K
    Response by Gibson and Fox to Letter Regarding Article, "Recurrent Hospitalization Among Patients With Atrial Fibrillation Undergoing Intracoronary Stenting Treated With 2 Treatment Strategies of Rivaroxaban or a Dose-Adjusted Oral Vitamin K Antagonis
    Circulation. 2017;136:117.
    PubMed    


  237. CERIT L
    Letter by Cerit Regarding Article, "Recurrent Hospitalization Among Patients With Atrial Fibrillation Undergoing Intracoronary Stenting Treated With 2 Treatment Strategies of Rivaroxaban or a Dose-Adjusted Oral Vitamin K Antagonist Treatment Strategy"
    Circulation. 2017;136:115-116.
    PubMed    


  238. BEACH LY, Goldschlager N, Moss JD, Scheinman MM, et al
    Idiopathic Ventricular Fibrillation in a 29-Year-Old Man.
    Circulation. 2017;136:112-114.
    PubMed    


    June 2017
  239. GOLWALA H, Bajaj NS, Arora G, Arora P, et al
    Response by Golwala et al to Letter Regarding Article, "Implantable Cardioverter-Defibrillator for Nonischemic Cardiomyopathy: An Updated Meta-Analysis".
    Circulation. 2017;135:e1200-e1202.
    PubMed    


  240. NERY PB, Lewis KB, Birnie DH
    Letter by Nery et al Regarding Article, "Implantable Cardioverter-Defibrillator for Nonischemic Cardiomyopathy: An Updated Meta-Analysis".
    Circulation. 2017;135:e1198-e1199.
    PubMed    


  241. BARAKAT AF, Saad M, Elgendy IY
    Letter by Barakat et al Regarding Article, "Implantable Cardioverter-Defibrillator for Nonischemic Cardiomyopathy: An Updated Meta-Analysis".
    Circulation. 2017;135:e1196-e1197.
    PubMed    


  242. LAMPERT R, Olshansky B, Heidbuchel H, Lawless C, et al
    Safety of Sports for Athletes With Implantable Cardioverter-Defibrillators: Long-Term Results of a Prospective Multinational Registry.
    Circulation. 2017;135:2310-2312.
    PubMed    


  243. COYLEWRIGHT M, Holmes DR Jr
    Caution Regarding Government-Mandated Shared Decision Making for Patients With Atrial Fibrillation.
    Circulation. 2017;135:2211-2213.
    PubMed    


  244. YAMAGATA K, Horie M, Aiba T, Ogawa S, et al
    Genotype-Phenotype Correlation of SCN5A Mutation for the Clinical and Electrocardiographic Characteristics of Probands With Brugada Syndrome: A Japanese Multicenter Registry.
    Circulation. 2017;135:2255-2270.
    PubMed     Abstract available


    May 2017
  245. FREEDMAN B, Camm J, Calkins H, Healey JS, et al
    Screening for Atrial Fibrillation: A Report of the AF-SCREEN International Collaboration.
    Circulation. 2017;135:1851-1867.
    PubMed     Abstract available


  246. LAU DH, Hendriks J, Kalman JM, Sanders P, et al
    Blood Pressure Control in Atrial Fibrillation: One of Many Critical Components in Risk Factor Modification.
    Circulation. 2017;135:1799-1801.
    PubMed    



  247. Correction to: Severe Pulmonary Vein Stenosis Resulting From Ablation for Atrial Fibrillation: Presentation, Management, and Clinical Outcomes.
    Circulation. 2017;135:e1016.
    PubMed    


  248. FENDER EA, Widmer RJ, Holmes DR Jr, Packer DL, et al
    Response by Fender et al to Letter Regarding Article, "Severe Pulmonary Vein Stenosis Resulting From Ablation for Atrial Fibrillation: Presentation, Management, and Clinical Outcomes".
    Circulation. 2017;135:e1014-e1015.
    PubMed    


  249. JAZAYERI MA, Reddy YM, Lakkireddy DR
    Letter by Jazayeri et al Regarding Article, "Severe Pulmonary Vein Stenosis Resulting From Ablation for Atrial Fibrillation: Presentation, Management, and Clinical Outcomes".
    Circulation. 2017;135:e1012-e1013.
    PubMed    


    April 2017
  250. FLYER JN, Zuckerman WA, Richmond ME, Anderson BR, et al
    Prospective Study of Adenosine on Atrioventricular Nodal Conduction in Pediatric and Young Adult Patients After Heart Transplant.
    Circulation. 2017 Apr 27. pii: CIRCULATIONAHA.117.028087.
    PubMed     Abstract available


  251. VERMA A, Kalman JM, Callans DJ
    Treatment of Patients With Atrial Fibrillation and Heart Failure With Reduced Ejection Fraction.
    Circulation. 2017;135:1547-1563.
    PubMed     Abstract available


  252. TJONG FV, Reddy VY
    Permanent Leadless Cardiac Pacemaker Therapy: A Comprehensive Review.
    Circulation. 2017;135:1458-1470.
    PubMed     Abstract available


  253. STRAUSS DG, Vicente J, Johannesen L, Blinova K, et al
    Common Genetic Variant Risk Score Is Associated With Drug-Induced QT Prolongation and Torsade de Pointes Risk: A Pilot Study.
    Circulation. 2017;135:1300-1310.
    PubMed     Abstract available


    March 2017
  254. SCHEINMAN MA, Rutherford JD
    The Development of Cardiac Arrhythmia Ablation: A Conversation With Melvin A. Scheinman, MD.
    Circulation. 2017;135:1191-1193.
    PubMed     Abstract available



  255. Correction to: Recurrent Hospitalization Among Patients With Atrial Fibrillation Undergoing Intracoronary Stenting Treated With 2 Treatment Strategies of Rivaroxaban or a Dose-Adjusted Oral Vitamin K Antagonist Treatment Strategy.
    Circulation. 2017;135:e789.
    PubMed    


  256. SISCOVICK DS, Barringer TA, Fretts AM, Wu JH, et al
    Omega-3 Polyunsaturated Fatty Acid (Fish Oil) Supplementation and the Prevention of Clinical Cardiovascular Disease: A Science Advisory From the American Heart Association.
    Circulation. 2017 Mar 13. pii: CIR.0000000000000482.
    PubMed     Abstract available


  257. RAVAL AN, Cigarroa JE, Chung MK, Diaz-Sandoval LJ, et al
    Management of Patients on Non-Vitamin K Antagonist Oral Anticoagulants in the Acute Care and Periprocedural Setting: A Scientific Statement From the American Heart Association.
    Circulation. 2017;135:e604-e633.
    PubMed     Abstract available


    February 2017
  258. WHITMAN IR, Gladstone RA, Badhwar N, Hsia HH, et al
    Brain Emboli After Left Ventricular Endocardial Ablation.
    Circulation. 2017;135:867-877.
    PubMed     Abstract available


  259. CARNICELLI AP, De Caterina R, Halperin JL, Renda G, et al
    Edoxaban for the Prevention of Thromboembolism in Patients with AtrialFibrillation and Bioprosthetic Valves.
    Circulation. 2017 Feb 16. pii: CIRCULATIONAHA.116.026714.
    PubMed     Abstract available


  260. CHOWDHURY SK, Liu W, Zi M, Li Y, et al
    Stress-Activated Kinase Mitogen-Activated Kinase Kinase-7 Governs Epigenetics of Cardiac Repolarization for Arrhythmia Prevention.
    Circulation. 2017;135:683-699.
    PubMed     Abstract available


  261. SIONTIS KC, Yao X, Gersh BJ, Noseworthy PA, et al
    Direct Oral Anticoagulants in Patients With Atrial Fibrillation and Valvular Heart Disease Other Than Significant Mitral Stenosis and Mechanical Valves: A Meta-Analysis.
    Circulation. 2017;135:714-716.
    PubMed    


  262. RAO MP, Al-Khatib SM, Pokorney S, She L, et al
    Sudden Cardiac Death in Patients with Ischemic Heart Failure Undergoing Coronary Artery Bypass Grafting: Results from the Surgical Treatment for Ischemic Heart Failure (STICH) Randomized Clinical Trial.
    Circulation. 2017 Feb 2. pii: CIRCULATIONAHA.116.026075.
    PubMed     Abstract available


    January 2017
  263. LA GERCHE A, Brosnan MJ
    Cardiovascular Effects of Performance-Enhancing Drugs.
    Circulation. 2017;135:89-99.
    PubMed     Abstract available


    December 2016
  264. WIBERG S, Hassager C, Schmidt H, Thomsen JH, et al
    Neuroprotective Effects of the Glucagon-Like Peptide-1 Analog Exenatide After Out-of-Hospital Cardiac Arrest: A Randomized Controlled Trial.
    Circulation. 2016;134:2115-2124.
    PubMed     Abstract available


  265. GOTO Y, Funada A, Goto Y
    Duration of Prehospital Cardiopulmonary Resuscitation and Favorable Neurological Outcomes for Pediatric Out-of-Hospital Cardiac Arrests: A Nationwide, Population-Based Cohort Study.
    Circulation. 2016;134:2046-2059.
    PubMed     Abstract available


    November 2016
  266. AL-KHATIB SM, Friedman P, Ellenbogen KA
    Defibrillators: Selecting the Right Device for the Right Patient.
    Circulation. 2016;134:1390-1404.
    PubMed     Abstract available


  267. ALVAREZ-GARCIA J, Vives-Borras M, Gomis P, Ordonez-Llanos J, et al
    Response by Alvarez-Garcia et al to Letters Regarding Article, "Electrophysiological Effects of Selective Atrial Coronary Artery Occlusion in Humans".
    Circulation. 2016;134:e401-e402.
    PubMed    


  268. BARANCHUK A
    Letter by Baranchuk Regarding Article, "Electrophysiological Effects of Selective Atrial Coronary Artery Occlusion in Humans".
    Circulation. 2016;134:e399-e400.
    PubMed    


  269. NG FS, Efimov IR
    Letter by Ng and Efimov Regarding Article, "Electrophysiological Effects of Selective Atrial Coronary Artery Occlusion in Humans".
    Circulation. 2016;134:e397-e398.
    PubMed    


    October 2016
  270. HAMPTON T
    Energy Drinks Pose Worrisome Risks to Adolescents' Cardiovascular Health.
    Circulation. 2016;134:1052-1053.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Arrhythmias is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: